Colin joined Charles River as an analytical scientist in support of bioanalytical validation studies and routine analytic studies utilizing HPLC with UV and mass spectrometry detection. He then moved into a study director role for both GLP and GCP studies. Currently, he manages a bioanalysis team of 32 who support GLP and GCP studies for in vitro, preclinical, and clinical phases of drug development.
Colin Pattison, BSc
Associate Director, Bioanalysis